Skip to main content
Starving cancer cells of a key amino acid could potentially render tumors more vulnerable to the body’s natural immune response.

Fuchs receives the honor for illuminating the genetics of skin diseases and the mechanisms that guide skin renewal, yielding insights into aging, inflammation, and cancer.

The body's first blush with a pathogen shapes how it will respond to vaccines. New evidence clarifies how this phenomenon works, mechanistically.

A diverse immune response hinges on naive B cells mingling with high affinity ones in the late-stage germinal center. Whether that helps or hinders, however, depends on the virus.

Charles David Allis, a molecular biologist who shaped the field of chromatin biology, died on January 8 at the age of 71.

It's not just the number of mutations that matters. It's the failure to fix them too.

A novel method reduces the time required to identify novel antibiotic-producing DNA from weeks to days.

While most germinal centers shut down after a few weeks, some stay in business for more than six months. A new study helps explain why.

Breakthroughs in genetics, biochemistry, neuroscience, infectious disease, and drug development were a few of the year's highlights.

The library is offering new tools and training to support researchers operating under an updated NIH policy.